Cases & Deals

  • Home
  • Practices
  • Celgene obtains dismissal in Washington product liability action

Share

Celgene obtains dismissal in Washington product liability action

May 2011

Client(s) Celgene Corporation

Jones Day, on behalf of Celgene Corporation, obtained a dismissal of a product liability suit against a host of drug and medical device manufacturers stemming from alleged heparin-induced thrombocytopenia or "HIT".

McFarland v. APP Pharmaceuticals, LLC, et al., Case No. 2:10-CV-01746 (W.D. Wash.)

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.